Reference
  1. Bronsteen R, Whitten A, Balasubramanian M, et al. Vasa previa: clinical presentations, outcomes, and implications for management. Obstet Gynecol. 2013; 122: 352-357
  2. Salomon LJ, Alfirevic Z, Berghella V, et al. ; ISUOG Clinical Standards Committee. Practice guidelines for performance of the routine mid-trimester fetal ultrasound scan. Ultrasound Obstet Gynecol. 2011 ;37 :116-126. doi: 10.1002/uog.8831. PMID: 20842655
  3. Prince GD. Unruptured vasa previa with anomalous umbilical cord formation: a case of postpartum physician tachycardia Can Fam Physician. 2013 ;59 :1076-1078. PMID: 24130283 PMCID: PMC3796974
  4. Ruiter L, Kok N, Limpens J, et al. Systematic review of accuracy of ultrasound in the diagnosis of vasa previa. Ultrasound Obstet Gynecol. 2015 ;45 :516.
  5. Aoki M, Obata S, Odagami M, Miyagi E, Aoki S. Prenatal diagnosis of vasa previa and the course of the cord vessels contribute to the safety of cesarean sections: A case report. Clin Case Rep. 2019 ;7 :2114-2117. doi: 10.1002/ccr3.2432. eCollection 2019 Nov. PMID: 31788261 PMCID: PMC6878040 DOI: 10.1002/ccr3.2432
  6. Liu W, Morito D, Takashima S, Mineharu Y, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One. 2011 ;6 :e22542. doi: 10.1371/journal.pone.0022542. Epub 2011 Jul 20. PMID: 21799892
  7. Bang OY, Chung JW, Kim DH, et al. Moyamoya Disease and Spectrums of RNF213 Vasculopathy. Transl Stroke Res. 2020 ;11 :580-589. doi: 10.1007/s12975-019-00743-6. Epub 2019 Oct 24. PMID: 31650369